Updates are available Correction dated 2020-03-17
Click to view Correction: https://doi.org/10.1038/s43018-020-0049-z
-
Authors
Pruessmann, Wiebke
Rytlewski, Julie http://orcid.org/0000-0001-5244-6790
Wilmott, James http://orcid.org/0000-0002-6750-5244
Mihm, Martin C. Jr
Attrill, Grace H.
Dyring-Andersen, Beatrice
Fields, Paul http://orcid.org/0000-0002-9608-6464
Zhan, Qian
Colebatch, Andrew J.
Ferguson, Peter M.
Thompson, John F. http://orcid.org/0000-0002-2816-2496
Kallenbach, Klaus
Yusko, Erik
Clark, Rachael A.
Robins, Harlan
Scolyer, Richard A. http://orcid.org/0000-0002-8991-0013
Kupper, Thomas S. http://orcid.org/0000-0002-4229-2916
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
Australian National Health and Medical Research Council Fellowships
University of Sydney
Novo Nordisk
Lundbeckfonden
U.S. Department of Health & Human Services | National Institutes of Health (R01 AI127654, R01 AI127654, R01 CA203721, R01 AR065807)
Medical Foundation of The University of Sydney
- License Information
-
More Information
Article History
Received: 30 September 2019
Accepted: 10 December 2019
First Online: 20 January 2020
Change Date: 17 March 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s43018-020-0049-z
Competing interests
: J.R., P.F., E.Y. and H.R. are or were employed by and have financial interest in Adaptive Biotechnologies. H.R. owns intellectual property associated with Adaptive Biotechnologies. T.S.K. serves on the Scientific Advisory Board (Hematology) of Adaptive Biotechnologies but does not own stock or receive compensation.
